Evidence map›Paper›PMID 36060956›Full record

ReviewFrontiers in endocrinology2022

Guidance for high-dose vitamin D supplementation for prolonging the honeymoon phase in children and adolescents with new-onset type 1 diabetes.

Benjamin Udoka Nwosu

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Benjamin Udoka NwosuDivision of Endocrinology, Department of Pediatrics, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY, United States.
University of Massachusetts Chan Medical School · US

Funding

Vitamin D and Residual Beta-Cell Function in Type 1 DiabetesR21DK113353 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI NWOSU, BENJAMIN UDOKA · 2017 to 2019
$628k
NIDDK NIH HHS R21 DK113353
6 · The paper itself

Abstract

The publication of our recent randomized controlled trial (RCT) showing that vitamin D could protect the β-cells during the honeymoon phase of type 1 diabetes (T1D) has led to calls for guidance for vitamin D supplementation during the critical phase of type 1 diabetes. Prolonging the partial clinical remission (PR) phase of TID improves glycemic control and reduces long-term complications of T1D. This RCT randomized 36 children and adolescents to either receive vitamin D

Indexed as

Diabetes Mellitus, Type 1Vitamin D DeficiencyAdolescentChildDietary SupplementsGlycated HemoglobinHumansRandomized Controlled Trials as TopicVitamin DVitaminsGlycated HemoglobinVitamin DVitaminshemoglobin A1choneymoon phaseinsulin dose adjusted A1cinsulin sensitivitypartial clinical remissiontype 1 diabetesvitamin D

Identifiers

PMID36060956
PMCPMC9433871
OpenAlexW4292416801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.